2.595
Precedente Chiudi:
$3.25
Aprire:
$2.8
Volume 24 ore:
451.36K
Relative Volume:
1.37
Capitalizzazione di mercato:
$8.71M
Reddito:
$556.00K
Utile/perdita netta:
$-5.28M
Rapporto P/E:
-1.2126
EPS:
-2.14
Flusso di cassa netto:
$-6.23M
1 W Prestazione:
+10.90%
1M Prestazione:
+1.96%
6M Prestazione:
-4.60%
1 anno Prestazione:
-5.64%
Cyclerion Therapeutics Inc Stock (CYCN) Company Profile
Nome
Cyclerion Therapeutics Inc
Settore
Industria
Telefono
617-621-7722
Indirizzo
301 BINNEY STREET, CAMBRIDGE, MA
Confronta CYCN con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
CYCN
Cyclerion Therapeutics Inc
|
2.61 | 10.41M | 556.00K | -5.28M | -6.23M | -2.14 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
380.31 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
447.62 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
555.25 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
708.64 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
328.54 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2021-10-20 | Iniziato | Truist | Buy |
2021-09-24 | Iniziato | Cantor Fitzgerald | Overweight |
2019-06-03 | Iniziato | Credit Suisse | Neutral |
Cyclerion Therapeutics Inc Borsa (CYCN) Ultime notizie
Real time scanner hits for Cyclerion Therapeutics Inc. explainedInsider Buying & Free Verified High Yield Trade Plans - newser.com
Cyclerion Therapeutics’ Licence Move: Boost or Bust? - StocksToTrade
Hengrui, Glenmark ink ADC deal; Rome Therapeutics to seek ‘strategic options’ - Endpoints News
Why Is Cyclerion Stock Surging In Pre-market Trade? - Nasdaq
Full technical analysis of Cyclerion Therapeutics Inc. stockPortfolio Value Summary & Verified Swing Trading Watchlist - newser.com
Cyclerion Therapeutics jumps on MIT deal to develop depression drug - TradingView
Why Did Cyclerion Therapeutics Stock Surge Nearly 50% After-Hours Today? - MSN
Cyclerion signs MIT license for treatment-resistant depression program By Investing.com - Investing.com Australia
Cyclerion signs MIT license for treatment-resistant depression program - Investing.com
Cyclerion Announces Transformational Relaunch As A Neuropsychiatric Company - TradingView
Cyclerion Therapeutics Enters License Agreement With MIT to Relaunch as Neuropsychiatric Firm - MarketScreener
Cyclerion Therapeutics Relaunches with Neuropsychiatric Focus - TipRanks
Cyclerion Therapeutics (CYCN) Secures MIT Licensing for Strategi - GuruFocus
Cyclerion Therapeutics Announces Strategic Relaunch and Licensing Agreement with MIT to Address Treatment-Resistant Depression - Quiver Quantitative
Cyclerion stock soars after MIT licensing deal to relaunch company - Investing.com
Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company - GlobeNewswire
Insiders Rewarded With US$55k Addition To Investment As Cyclerion Therapeutics Stock Hits US$7.6m - simplywall.st
Best data tools to analyze Cyclerion Therapeutics Inc. stockWeekly Risk Report & Accurate Technical Buy Alerts - newser.com
Cyclerion Therapeutics Inc. stock volume spike explainedMarket Trend Review & Growth Focused Stock Reports - newser.com
How to use a screener to detect Cyclerion Therapeutics Inc. breakoutsStock Surge & Momentum Based Trading Signals - newser.com
What MACD signals say about Cyclerion Therapeutics Inc.Trend Reversal & Stepwise Trade Execution Plans - newser.com
Multi asset correlation models including Cyclerion Therapeutics Inc.July 2025 Sector Moves & Risk Controlled Stock Alerts - newser.com
Quarterly Earnings: Is Cyclerion Therapeutics Incs growth already priced inShort Setup & Technical Pattern Alert System - خودرو بانک
Using RSI to spot recovery in Cyclerion Therapeutics Inc.2025 Price Momentum & Short-Term Trading Alerts - newser.com
Will Cyclerion Therapeutics Inc. bounce back from current supportJuly 2025 Retail & Smart Allocation Stock Tips - newser.com
Strategies to average down on Cyclerion Therapeutics Inc.Inflation Watch & Target Return Focused Picks - newser.com
Will Cyclerion Therapeutics Inc. stock recover after recent dropJuly 2025 Opening Moves & Scalable Portfolio Growth Ideas - newser.com
Exit strategy if you’re trapped in Cyclerion Therapeutics Inc.July 2025 PostEarnings & Real-Time Volume Trigger Notifications - newser.com
Update Recap: Can Cyclerion Therapeutics Inc deliver alphaJuly 2025 Momentum & Community Driven Trade Alerts - خودرو بانک
Buyback Watch: Should I invest in Cyclerion Therapeutics Inc before earningsWeekly Market Outlook & AI Forecasted Entry/Exit Points - خودرو بانک
Aug Retail: Does Cyclerion Therapeutics Inc meet Warren Buffetts criteria2025 Trade Ideas & Community Verified Watchlist Alerts - خودرو بانک
Buyback Watch: Is Cyclerion Therapeutics Inc a good ESG investmentQuarterly Investment Review & Reliable Intraday Trade Alerts - khodrobank.com
Is Cyclerion Therapeutics Inc stock a good pick for beginnersWeekly Profit Recap & Daily Price Action Insights - خودرو بانک
Aug Volume: Will Cyclerion Therapeutics Inc. benefit from geopolitical trends2025 Earnings Surprises & Low Risk Entry Point Tips - خودرو بانک
Aug Volume: Is Cyclerion Therapeutics Inc stock a good pick for beginnersJuly 2025 Reactions & Verified Entry Point Detection - خودرو بانک
Aug Rallies: What analysts say about Cyclerion Therapeutics Inc. stock2025 Momentum Check & Free High Accuracy Swing Entry Alerts - khodrobank.com
Momentum Shift: What is the target price for Cyclerion Therapeutics Inc stockWeekly Investment Report & Free Fast Gain Swing Trade Alerts - خودرو بانک
Using economic indicators to assess Cyclerion Therapeutics Inc. potential2025 Analyst Calls & AI Enhanced Trade Execution Alerts - newser.com
Is this a good reentry point in Cyclerion Therapeutics Inc.Weekly Gains Report & AI Driven Price Forecasts - newser.com
Will Cyclerion Therapeutics Inc. price bounce be sustainableMarket Growth Summary & Short-Term Trading Opportunity Alerts - newser.com
Cyclerion Therapeutics Inc Azioni (CYCN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):